Results
13
Companies with a market cap of more than US$1B, strong financial health, modest PE ratios, past earnings growth and paying a dividend.
13 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
TRI | €106.60 | -4.0% | -21.4% | €2.1b | €180.06 | PE5.6x | E-5.4% | 3.3% | Automobiles | ||
TFI | €8.12 | -3.0% | 23.1% | €1.7b | €10.33 | PE8.9x | E9.8% | 6.8% | Media | ||
PEUG | €90.10 | -2.7% | -16.7% | €2.2b | €148.33 | PE16.4x | E20.1% | 3.6% | Diversified Financials | ||
CATR | US$327.00 | -3.4% | 64.7% | US$170.6b | US$318.47 | PE15.2x | E-1.9% | 1.5% | Capital Goods | ||
LOUP | €143.00 | -1.7% | 11.7% | €2.5b | €179.62 | PE8.1x | E2.0% | 1.9% | Food, Beverage & Tobacco | ||
ATE | €101.10 | -7.3% | -29.9% | €3.5b | €149.94 | PE15.1x | E11.2% | 1.5% | Software | ||
IPS | €62.35 | -0.4% | 40.0% | €2.7b | €76.25 | PE14.8x | E12.5% | 2.6% | Media | ||
IPN | €111.00 | 0.4% | -1.9% | €9.2b | €127.59 | PE14.9x | E6.7% | 1.1% | Pharmaceuticals & Biotech | ||
ENX | €91.95 | -0.4% | 42.4% | €9.5b | €101.49 | PE17.1x | E6.9% | 2.7% | Diversified Financials | ||
TE | €23.54 | -1.8% | 6.0% | €4.2b | €26.46 | PE13.6x | E11.9% | 2.4% | Energy | ||
PUB | €98.10 | -2.0% | 33.8% | €24.6b | €111.93 | PE16.8x | E5.0% | 3.5% | Media | ||
ML | €34.45 | -0.8% | 16.5% | €24.6b | €37.13 | PE12.4x | E10.1% | 3.9% | Automobiles | ||
CDI | €618.00 | -4.8% | -21.7% | €111.5b | n/a | PE19.2x | n/a | 2.1% | Consumer Durables |